Patient-reported outcomes of BMT CTN 1703: A randomized phase III study for GVHD prophylaxis - A quality of life evaluation Meeting Abstract
| Authors: | Holtan, S. G.; Martens, M. J.; Al Malki, M. M.; Efebera, Y.; Kitko, C. L.; Reshef, R.; Rezvani, A. R.; Shaffer, B. C.; Solh, M. M.; Yao, J. M.; Runaas, L.; Elmariah, H.; Larkin, K. T.; El Jurdi, N. H.; Gooptu, M.; Loren, A. W.; Hall, A. C.; Alousi, A.; Jamy, O.; Clark, W.; Kean, L.; Bhatt, A. S.; Perales, M. A.; Applegate, K.; WU, J.; Liefer, E.; DiFronzo, N.; Jones, R. J.; Horowitz, M. M.; Mattila, D.; Hamadani, M.; Bolanos-Meade, J. |
| Abstract Title: | Patient-reported outcomes of BMT CTN 1703: A randomized phase III study for GVHD prophylaxis - A quality of life evaluation |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 897 |
| Language: | English |
| ACCESSION: | WOS:001159306703166 |
| DOI: | 10.1182/blood-2023-187859 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
